Conversely, K17 has been associated with immune cell response in psoriasis as well as in basal cell skin cancer and in cervical carcinoma and is a negative prognostic biomarker in PDAC, suggesting that K17 might have some role in CD8+ T cell exclusion [60, 66]. The gene discussed is KRT17; the disease is skin basal cell carcinoma.